National Research ( (NRC) ) has released its Q1 earnings. Here is a breakdown of the information National Research presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
National Research Corporation, operating as NRC Health, is a company dedicated to enhancing healthcare systems’ understanding of patients and communities through personalized insights, primarily within the healthcare sector. In its first quarter of 2025, NRC Health reported a sequential increase in total recurring contract value, marking a significant milestone in its revenue growth strategy. This achievement is attributed to the expansion and rebuilding of its sales force, which has also led to increased sales and win rates. Additionally, the company announced a new share repurchase program and declared a quarterly dividend, reflecting its commitment to delivering shareholder value. Key financial metrics from the quarter include a slight decrease in revenue to $33.6 million from $35.3 million in the previous year, alongside a reduction in operating expenses. Despite a decline in net income to $5.8 million from $6.4 million, the company remains focused on strategic growth initiatives. Looking ahead, NRC Health is poised to continue its growth trajectory under the leadership of incoming CEO Trent Green, with plans to further expand its sales force and capitalize on its unique market position.